A typical GLP-1 microdosing schedule starts at 0.05 to 0.1 mg of semaglutide weekly (versus 0.25 mg standard), with gradual increases every four weeks based on tolerance and response
& Guestrin, C
Shigematsu N, Kawashiri T, Kobayashi D, Shimizu S, Mine K, Hiromoto S, Uchida M, Egashira N, Shimazoe T (2020) Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro
Beneath the skin lies the subcutaneous fat layer
GHK-Cu contributes cardiovascular protection through its antioxidant and anti-inflammatory properties combined with pro-angiogenic activity essential for maintaining adequate tissue perfusion
The question is whether the added glucagon receptor effects, including the heart rate increase, will enhance, diminish, or have no effect on that protection